Deciding to Initiate Antiviral Treatment in Patients with Chronic Hepatitis B Virus Infection
This answer is incorrect. Treatment of hepatitis B infection with lamivudine (Epivir) has not been shown to precipitate hepatic decompensation in patients with compensated cirrhosis, but has been associated with delay of progression to death or liver transplantation. Preliminary results with adefovir (Hepsera) and entecavir (Baraclude) indicate that these oral nucleosides are safe in patients with cirrhosis and may also prevent or delay transplantation.
Choose another answer: